Drugs target to CSNK1E

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
UMBRALISIBSmall moleculeMantle cell lymphomaCasein kinase I epsilon inhibitor1.0TerminatedClinicalTrials
UMBRALISIB TOSYLATESmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor1.0Active, not recruitingClinicalTrials
UMBRALISIBSmall moleculeMantle cell lymphomaCasein kinase I epsilon inhibitor2.0SuspendedClinicalTrials
UMBRALISIBSmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor1.0Active, not recruitingClinicalTrials
UMBRALISIBSmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor2.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor3.0Active, not recruitingClinicalTrials
UMBRALISIB TOSYLATESmall moleculepolycythemia veraCasein kinase I epsilon inhibitor1.0Active, not recruitingClinicalTrials
UMBRALISIB TOSYLATESmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor2.0TerminatedClinicalTrials
UMBRALISIBSmall moleculediffuse large B-cell lymphomaCasein kinase I epsilon inhibitor2.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculefollicular lymphomaCasein kinase I epsilon inhibitor2.0TerminatedClinicalTrials
UMBRALISIBSmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor2.0SuspendedClinicalTrials
UMBRALISIBSmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculerectum cancerCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculeWaldenstrom macroglobulinemiaCasein kinase I epsilon inhibitor2.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculefollicular lymphomaCasein kinase I epsilon inhibitor4.0-DailyMed,FDA
UMBRALISIB TOSYLATESmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor2.0CompletedClinicalTrials
UMBRALISIBSmall moleculerectum cancerCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculeMantle cell lymphomaCasein kinase I epsilon inhibitor1.0Active, not recruitingClinicalTrials
UMBRALISIBSmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor1.0TerminatedClinicalTrials
UMBRALISIBSmall moleculepancreatic carcinomaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculeHodgkins lymphomaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculecolorectal carcinomaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculemyelofibrosisCasein kinase I epsilon inhibitor1.0Active, not recruitingClinicalTrials
UMBRALISIB TOSYLATESmall moleculepancreatic carcinomaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculecolorectal carcinomaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculemyelofibrosisCasein kinase I epsilon inhibitor1.0Active, not recruitingClinicalTrials
UMBRALISIBSmall moleculeneoplasm of mature B-cellsCasein kinase I epsilon inhibitor1.0RecruitingClinicalTrials
UMBRALISIBSmall moleculefollicular lymphomaCasein kinase I epsilon inhibitor2.0TerminatedClinicalTrials
UMBRALISIBSmall moleculefollicular lymphomaCasein kinase I epsilon inhibitor2.0RecruitingClinicalTrials
UMBRALISIBSmall moleculefollicular lymphomaCasein kinase I epsilon inhibitor4.0-FDA,DailyMed
UMBRALISIB TOSYLATESmall moleculeMantle cell lymphomaCasein kinase I epsilon inhibitor1.0Active, not recruitingClinicalTrials
UMBRALISIBSmall moleculeunspecified peripheral T-cell lymphomaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculemarginal zone B-cell lymphomaCasein kinase I epsilon inhibitor4.0-FDA
UMBRALISIBSmall moleculefollicular lymphomaCasein kinase I epsilon inhibitor2.0SuspendedClinicalTrials
UMBRALISIB TOSYLATESmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculegastric cancerCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculediffuse large B-cell lymphomaCasein kinase I epsilon inhibitor2.0CompletedClinicalTrials
UMBRALISIBSmall moleculefollicular lymphomaCasein kinase I epsilon inhibitor1.0Not yet recruitingClinicalTrials
UMBRALISIBSmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor2.0Active, not recruitingClinicalTrials
UMBRALISIB TOSYLATESmall moleculeesophageal cancerCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculemarginal zone B-cell lymphomaCasein kinase I epsilon inhibitor4.0-FDA
UMBRALISIBSmall moleculediffuse large B-cell lymphomaCasein kinase I epsilon inhibitor2.0TerminatedClinicalTrials
UMBRALISIBSmall moleculepolycythemia veraCasein kinase I epsilon inhibitor1.0Active, not recruitingClinicalTrials
UMBRALISIB TOSYLATESmall moleculegastrointestinal stromal tumorCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor3.0Active, not recruitingClinicalTrials
UMBRALISIBSmall moleculeHodgkins lymphomaCasein kinase I epsilon inhibitor2.0TerminatedClinicalTrials
UMBRALISIBSmall moleculeesophageal cancerCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculegastrointestinal stromal tumorCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculeHodgkins lymphomaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor2.0TerminatedClinicalTrials
UMBRALISIB TOSYLATESmall moleculegastric cancerCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIB TOSYLATESmall moleculeunspecified peripheral T-cell lymphomaCasein kinase I epsilon inhibitor1.0CompletedClinicalTrials
UMBRALISIBSmall moleculechronic lymphocytic leukemiaCasein kinase I epsilon inhibitor2.0RecruitingClinicalTrials